Common Stock, $0.01 par value
- Symbol
- INBS
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 8.01 · 8-K
Intelligent Bio Solutions Inc.
INBSNASDAQEQUITYCurrent
Other Events
Item 8.01 Other Events. Shares Outstanding Update As a result of (a) the exercise of previously disclosed outstanding prefunded warrants to purchase 285,000 shares of common stock, and (b) the issuance of 4,333 shares of restricted common stock pursuant to the previously disclosed Investor Relations and Corporate Development Advisory Agreement, dated February 29, 2024, the total number of outstand…
Company context
Bio Solutions Inc. Intelligent Bio Solutions Inc. (Nasdaq: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the U.S. include construction, manufacturing and engineering, transport and logistics firms, mining, drug treatment organizations, and coroners.
Current securities
Registered securities in this filing
INTELLIGENT BIO SOLUTIONS INC. · 8-K · Filed 2026-09-11
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item
8.01 Other Events.
Shares
Outstanding Update
As
a result of (a) the exercise of previously disclosed outstanding prefunded warrants to purchase 285,000 shares of common stock, and (b)
the issuance of 4,333 shares of restricted common stock pursuant to the previously disclosed Investor Relations and Corporate Development
Advisory Agreement, dated February 29, 2024, the total number of outstanding shares of the Company’s common stock as of the close
of business on September 10, 2026, is 3,316,803 shares.